We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$770M
AUM Growth
+$130M
Cap. Flow
+$122M
Cap. Flow %
15.79%
Top 10 Hldgs %
26%
Holding
984
New
94
Increased
180
Reduced
306
Closed
93

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$45.5M
2
MSFT icon
Microsoft
MSFT
+$17M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.08M
4
AMZN icon
Amazon
AMZN
+$7.25M
5
PLMR icon
Palomar
PLMR
+$7.01M

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Staples 7.79%
3 Financials 6.32%
4 Healthcare 4.92%
5 Consumer Discretionary 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STIP icon
151
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$778K 0.1%
+7,816
New +$775K
LH icon
152
Labcorp
LH
$25.8B
$766K 0.1%
3,764
-321
-8% -$65.3K
CSCO icon
153
Cisco
CSCO
$476B
$759K 0.1%
15,976
+9,918
+164% +$471K
VB icon
154
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
$756K 0.1%
3,469
-370
-10% -$81.3K
IEUS icon
155
iShares MSCI Europe Small-Cap ETF
IEUS
$185M
$751K 0.1%
13,431
+1,803
+16% +$103K
DVA icon
156
DaVita
DVA
$11.4B
$743K 0.1%
5,361
-893
-14% -$123K
HMC icon
157
Honda
HMC
$41.2B
$739K 0.1%
22,927
-758
-3% -$25.6K
MUFG icon
158
Mitsubishi UFJ Financial
MUFG
$254B
$737K 0.1%
68,210
-7,166
-10% -$72.7K
TM icon
159
Toyota
TM
$224B
$735K 0.1%
3,584
-187
-5% -$41.4K
CAH icon
160
Cardinal Health
CAH
$56B
$727K 0.09%
7,398
-2,017
-21% -$206K
VST icon
161
Vistra
VST
$46.3B
$725K 0.09%
8,431
-1,490
-15% -$125K
SCHV
162
Schwab US Large-Cap Value ETF
SCHV
$16B
$721K 0.09%
29,187
FFH
163
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
$719K 0.09%
632
-9
-1% -$10.2K
RGA icon
164
Reinsurance Group of America
RGA
$15.9B
$719K 0.09%
3,503
+217
+7% +$43.3K
UNM icon
165
Unum
UNM
$14.1B
$715K 0.09%
13,999
-1,267
-8% -$65.6K
VNT icon
166
Vontier
VNT
$5.02B
$713K 0.09%
18,673
-1,914
-9% -$77.2K
TEVA icon
167
Teva Pharmaceuticals
TEVA
$41.3B
$713K 0.09%
43,891
+149
+0.3% +$2.29K
FENY icon
168
Fidelity MSCI Energy Index ETF
FENY
$1.94B
$711K 0.09%
28,332
-2,462
-8% -$63K
MOAT icon
169
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$710K 0.09%
8,201
-625
-7% -$54.3K
CMCSA icon
170
Comcast
CMCSA
$89.9B
$700K 0.09%
17,883
-4,814
-21% -$188K
AMKR icon
171
Amkor Technology
AMKR
$13.6B
$700K 0.09%
17,486
+9,370
+115% +$310K
COIN icon
172
Coinbase
COIN
$40.4B
$699K 0.09%
3,147
-753
-19% -$173K
KB icon
173
KB Financial Group
KB
$43.4B
$692K 0.09%
12,222
+1,003
+9% +$54.5K
AER icon
174
AerCap
AER
$24.1B
$689K 0.09%
7,388
-84
-1% -$7.48K
GDDY icon
175
GoDaddy
GDDY
$11.8B
$685K 0.09%
4,905
+342
+7% +$45.1K

Similar funds

Atlas Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Atlas Capital Advisors held 984 positions worth $770M, up 20% from $640M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Atlas Capital Advisors deployed $122M of net new capital in Q2 2024, opening 94 new positions and adding to 180 existing holdings. Its largest new stake was Prudential Financial: 8,398 shares worth $984K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.6% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was iShares MSCI Intl Momentum Factor ETF, an estimated $3.1M trimmed.

  • Atlas Capital Advisors's largest Q2 2024 buy was Prudential Financial: 8,398 shares worth $984K.
  • Atlas Capital Advisors added most to Procter & Gamble in Q2 2024, an estimated $45.5M increase.
  • Atlas Capital Advisors's biggest Q2 2024 reduction was iShares MSCI Intl Momentum Factor ETF, cutting an estimated $3.1M.
  • Atlas Capital Advisors fully exited Affirm in Q2 2024, selling an estimated $510K.
  • Atlas Capital Advisors's ten largest holdings make up 26% of its $770M portfolio in Q2 2024.
  • Atlas Capital Advisors opened 94 new positions and closed 93 in Q2 2024.
  • Atlas Capital Advisors's portfolio value rose 20% quarter-over-quarter to $770M.

Based on Atlas Capital Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.